Miniatura

Fitxers

733409.pdf (270.4 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-02-11

Llicència de publicació

cc-by-nc-nd (c) Humbert, Marc et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/197012

Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.healun.2022.02.002

Resum

EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study in patients with pulmonary hypertension treated with riociguat. Patients were followed for 1-4 years, and the primary outcomes were adverse events (AEs) and serious AEs (SAEs), including embolic/thrombotic and hemorrhagic events. Here we report data on patients with chronic thromboembolic pulmonary hypertension (CTEPH) receiving a vitamin K antagonist (VKA; n = 683) or a non-vitamin K antagonist oral anticoagulant (NOAC; n = 198) at baseline. AEs and SAEs were reported in 438 patients (64.1%) and 257 patients (37.6%), respectively, in the VKA group, and in 135 patients (68.2%) and 74 patients (37.4%) in the NOAC group. Exposure-adjusted hemorrhagic event rates were similar in the two groups, while exposure-adjusted embolic and/or thrombotic event rates were higher in the NOAC group, although the numbers of events were small. Further studies are required to determine the long-term effects of anticoagulation strategies in CTEPH.

Matèries

Hipertensió pulmonar, Malalties cròniques, Anticoagulants (Medicina), Efectes secundaris dels medicaments, Vitamines K

Matèries (anglès)

Pulmonary hypertension, Chronic diseases, Anticoagulants (Medicine), Drug side effects, Vitamin K

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

HUMBERT, Marc, SIMONNEAU, Gérald, PITTROW, David, DELCROIX, Marion, PEPKE-ZABA, Joanna, LANGLEBEN, David, MIELNICZUK, Lisa m., ESCRIBANO SUBIAS, Pilar, SNIJDER, Repke j., BARBERÀ I MIR, Joan albert, KLOTSCHE, Jens, MEIER, Christian, HOEPER, Marius m. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. _Journal of Heart and Lung Transplantation_. 2022. Vol. 41, núm. 6, pàgs. 716-721. [consulta: 24 de gener de 2026]. ISSN: 1053-2498. [Disponible a: https://hdl.handle.net/2445/197012]

Exportar metadades

JSON - METS

Compartir registre